571-765-7700
Examiners Not Likely to Even Answer PTAB Appeal Briefs
|
Many PTAB appeal briefs are not answered by the Examining Corps, thereby leading to favorable results for the patent applicants
MS Treatment Patent Invalid for Lack of Written Description
|
The patent specification did not support a claim to a specific dose of 480 mg/day of DMF, sold under the brand name Tecfidera for the treatment of MS
Federal Circuit Affirms PTAB Decision Finding Claimed Amount Had Written Description Support and Claimed Ranges Did Not
|
Held: Written description cases are intensively fact-oriented and a disclosure with isolated examples does not support claimed ranges with lower and upper bounds
Examiners Not Likely to Even Answer PTAB Appeal Briefs
|
Many PTAB appeal briefs are not answered by the Examining Corps, thereby leading to favorable results for the patent applicants
MS Treatment Patent Invalid for Lack of Written Description
|
The patent specification did not support a claim to a specific dose of 480 mg/day of DMF, sold under the brand name Tecfidera for the treatment of MS
Federal Circuit Affirms PTAB Decision Finding Claimed Amount Had Written Description Support and Claimed Ranges Did Not
|
Held: Written description cases are intensively fact-oriented and a disclosure with isolated examples does not support claimed ranges with lower and upper bounds
Look Around the Archives